Clinical Trials

The intersection of computational intelligence and molecular biology has revealed a shocking source for the next generation of life-saving medicine: the same infectious proteins responsible for devastating neurological disorders like Creutzfeldt-Jakob disease. Researchers at the Perelman School of

The critical window following an aneurysmal subarachnoid hemorrhage often determines the thin line between a successful recovery and permanent neurological deficit for thousands of patients every single year. These life-threatening brain bleeds require immediate and precise pharmacological

Group B Streptococcus remains a formidable adversary in the realm of neonatal health, contributing to significant rates of sepsis, pneumonia, and meningitis in infants globally. Pfizer’s hexavalent Group B Streptococcus vaccine, known as GBS6, has recently reached a pivotal moment in its

The oncological landscape has fundamentally shifted as researchers move away from the defeatist "undruggable" label that once defined the KRAS gene for nearly four decades of clinical frustration and failure. Today, the medical community is pivoting from merely managing terminal, late-stage

Recent breakthroughs in genomic analysis have fundamentally altered how clinicians perceive the origins of Amyotrophic Lateral Sclerosis (ALS), a condition traditionally viewed through the narrow lens of neurochemistry alone. This devastating neurodegenerative disease causes the progressive death

The medical landscape underwent a seismic shift recently when the Christie NHS Foundation Trust and the Royal Marsden launched the ZI-MA4-1 clinical trial, marking a pivotal moment for patients diagnosed with advanced solid tumors that have resisted standard treatments. For individuals like Tracy